Vascular endothelial growth factor inhibitors and hypertension: A central role for the kidney and endothelial factors?

Hypertension

Volumn 54, Issue 3, 2009, Pages 465-467

  Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ARGININE METHYL ESTER; ENDOTHELIN; NITRIC OXIDE; PROSTAGLANDIN; THROMBOXANE; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; MONOCLONAL ANTIBODY; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ALDOSTERONE URINE LEVEL; ANGIOGENESIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; HYPERTENSION; KIDNEY; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; URINARY EXCRETION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD PRESSURE; ENZYME INHIBITORS; GENE EXPRESSION; HYPERTENSION; KIDNEY; MICE; MODELS, BIOLOGICAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70349263578     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.132274     Document Type: Note

References (16)

1. Maharaj A, D'Amore PA. Roles for VEGF in adult. Microvasc Res. 2007;74:100-113.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31.
3. Karumanchi SA, Lindheimer MD. Preeclampsia pathogenesis: "triple a rating"-autoantibodies and antiangiogenic factors. Hypertension. 2008; 51:991-992.
4. LaMarca BD, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension. 2008;51:982-988.
5. Zhu X, Wu S, Dahut WL, Parikh CR. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am J Kidney Dis. 2007;49:186-193.
6. Zhu X, Stergiopoulos K, Wu S. Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis. Acta Oncol. 2009;48:9-17.
7. Dhaun N, Goddard J, Kohan DE, Pollock DM, Schiffrin EL, Webb DJ. Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension. 2008;52:452-459.
8. Tang EH, Vanhoutte PM. Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions. Pharmacol Ther. 2009; 122:140-149.
9. Facemire CS, Nixon AB, Griffiths R, Hurwitz H, Coffman TM. Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension. 2009;54:652-658.
10. Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol. 1998;274:H1054-H1058.
11. Wu HM, Huang Q, Yuan Y, Granger HJ. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol. 1996;271: H2735-H2739.
12. Morbidelli L, Chang C-H, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol. 1996;270:H411-H415.
13. Granger JP, Hall JE. Role of the kidney sodium and fluid excretion in hypertension. In: Lip GYP, Hall JE, eds. Comprehensive Hypertension. New York, NY: Elsevier; 2007:241-263.
14. Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol. 2006;17: 724-735.
15. Advani A, Kelly DJ, Advani SL, Cox AJ, Thai K, Zhang Y, White KE, Gow RM, Marshall SM, Steer BM, Marsden PA, Rakoczy PE, Gilbert RE. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc Natl Acad Sci U S A. 2007;104:14448-14453.
16. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-Cdependent buffering mechanism. Nat Med. 2009;15:545-552.